Patent ID: 8686043
Filing Date: 2014-04-01
Classification: A61P,C07C,C07D

Abstract:
1. A method for treating an AMPA receptor-mediated condition in a mammal selected from the group consisting of dementia, Alzheimer's disease, cognitive disorders, idiopathic and drug-induced Parkinson's disease, psychosis, schizophrenia, mood disorders, depression, attention deficit/hyperactivity disorder, and attention deficit disorder, comprising administering to the mammal a compound of formula I, or a pharmaceutically acceptable salt thereof, wherein each R m is zero, or one; n is zero, one, two or three; p is zero; q is zero; s is one and t is one; or one of s or t is one and the other of s or t is two; R each R R R R each R R ring “A” is (C ring “B” is phenyl or pyridinyl; “X” is —O— or >C(R “Y” is absent; and “Z” is —O.